Receptors, Vascular Endothelial Growth Factor, antagonists & inhibitors
- Name
- Receptors, Vascular Endothelial Growth Factor, antagonists & inhibitors
- Accession Number
- DBCAT001819
- Description
Not Available
- Drugs
Drug Drug Description Pazopanib An antineoplastic agent used in the treatment of advanced renal cell cancer and advanced soft tissue sarcoma in patients with prior chemotherapy. Tivozanib A kinase inhibitor to treat adult patients with renal cell carcinoma (RCC) who have failed prior systemic therapies or experienced relapsed disease. AEE-788 AEE788 has been used in trials studying the treatment of Cancer, Glioblastoma Multiforme, and Brain and Central Nervous System Tumors. Foretinib Foretinib has been used in trials studying the treatment of Cancer, Breast Cancer, Carcinoma, Renal Cell, Recurrent Breast Cancer, and Neoplasms, Head and Neck, among others. Foretinib is an orally... - Drugs & Drug Targets